Treatment advances, combination therapies, an increasing number of cancer treatment centers, a large number of regulatory approvals for metastatic gastric cancer, and low dose radiation technology-based devices are major drivers for the stomach cancer market. Furthermore, the introduction of new therapies for metastatic stomach cancer is expected to drive market growth in the near future. However, a lack of adequate financial assistance from health insurance policies, as well as stringent regulatory procedures for approving complex radiation devices, are the major factors that could stymie stomach cancer market growth over the forecast period.
Read More…